Schedule of Components of Basic and Diluted Earnings Per Share |
The components of basic and diluted earnings per share were as follows:
|
|
For the three months ended
March 31, 2021 |
|
|
For the nine months ended
March 31, 2021 |
|
|
|
Net Loss |
|
|
Shares |
|
|
Per Share |
|
|
Net Loss |
|
|
Shares |
|
|
Per Share |
|
Basic loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss available to common shareholders |
|
$ |
(623,231 |
) |
|
|
11,343,406 |
|
|
$ |
(0.05 |
) |
|
$ |
(147,781 |
) |
|
|
11,571,878 |
|
|
$ |
(0.01 |
) |
Effect of dilutive securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share grants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Diluted loss per share |
|
$ |
(623,231 |
) |
|
|
11,343,406 |
|
|
$ |
(0.05 |
) |
|
$ |
(147,781 |
) |
|
|
11,571,878 |
|
|
$ |
(0.01 |
) |
|
|
For the three months ended
March 31, 2020 |
|
|
For the nine months ended
March 31, 2020 |
|
|
|
Net Income |
|
|
Shares |
|
|
Per Share |
|
|
Net Loss |
|
|
Shares |
|
|
Per Share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic income (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to common shareholders |
|
$ |
1,000,807 |
|
|
|
11,753,063 |
|
|
$ |
0.09 |
|
|
$ |
(241,165 |
) |
|
|
11,713,827 |
|
|
$ |
(0.02 |
) |
Effect of dilutive securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share grants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Diluted income (loss) per share |
|
$ |
1,000,807 |
|
|
|
11,753,063 |
|
|
$ |
0.09 |
|
|
$ |
(241,165 |
) |
|
|
11,713,827 |
|
|
$ |
(0.02 |
) |
|
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following potential dilutive shares were excluded
from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive.
|
|
For the Three Months |
|
|
For the Nine Months |
|
|
|
Ended March 31, |
|
|
Ended March 31, |
|
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share Grants |
|
|
30,699 |
|
|
|
101,790 |
|
|
|
30,699 |
|
|
|
101,790 |
|
|
|
|
30,699 |
|
|
|
101,790 |
|
|
|
30,699 |
|
|
|
101,790 |
|
|